DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

Cell

Volumn 91, Issue 3, 1997, Pages 325-334

  Shieh, Sheau Yann ^a   Ikeda, Masako ^b   Taya, Yoichi ^c   Prives, Carol ^a  

^a Columbia University ^*  (United States)

^b Medical & Biological Laboratories Co Ltd   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; PROTEIN KINASE; PROTEIN P53;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; DOWN REGULATION; ENZYME PURIFICATION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION;

EID: 0030667702     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80416-X     Document Type: Article

References (62)

1. Avantaggiati, M.L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A.S., and Kelly, K. (1997). Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89, 1175-1184.
2. Blunt, T., Finnie, N.J., Taccioli, G.E., Smith, G.C.M., Demengeot, J., Gottlieb, T.M., Mizuta, R., Barghese, A.J., Alt, F.W., Jeggo, P.A., and Jackson, S.P. (1995). Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80, 813-823.
3. Böttger, V., Böttger, A., Howard, S.F., Picksley, S.M., Chéne, P., Garcia-Echeverria, C, Hochkeppel, H.-K., and Lane, D.P. (1996). Identification of novel mdm2 binding peptides by phage display. Oncogene 13, 2141-2147.
4. Canman, C.E., Wolff, A.C., Chen, C.-Y., Fornace, Jr., A.J., and Kastan, M.B. (1994). The p53-dependent G1 checkpoint pathway and ataxia-telangiectasia. Cancer. Res. 54, 5054-5058.
5. Carter, T., Vancurova, I., Sun, I., Lou, W., and DeLeon, S. (1990). A DNA-activated protein kinase from HeLa cell nuclei. Mol. Cell. Biol. 10, 6460-6471.
6. Chen, J., Marechal, V., and Levine, A.J. (1993). Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13, 4107-4114.
7. Danska, J.S., Holland, D.P. Mariathasan, S., Williams, K.M., and Guidos, C.J. (1996). Biochemical and genetic defects in the DNA-dependent protein kinase in murine acid lymphocyte. Mol. Cell. Biol. 16, 5507-5517.
8. de Oca Luna, R.M., Wagner, D.S., and Lozano, G. (1995). Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206.
9. Farmer, G., Bargonetti, J., Zhu, H., Friedman, P., Prywes, R., and Prives, C. (1992). Wild-type p53 activates transcription in vitro. Nature 358, 83-86.
10. Finnie, N.J., Gottlieb, T.M., Blunt, T., Jeggo, P.A., and Jackson, S.P. (1995). DNA-dependent protein kinase activity is absent in xrs-6 cells: implications for site-specific recombination and DNA double-strand break repair. Proc. Natl. Acad. Sci. USA 92, 320-324.
11. Fiscella, M., Ullrich, S.J., Zambrano, N., Shields, M.T., Lin, D., Lees-Miller, S.P., Anderson, C.W., Mercer, W.E., and Appella, E. (1993). Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 8, 1519-1528.
12. Fried, L.M., Koumenis, C., Peterson, S.R., Green, S.L., van Zijl, P., Allalunis-Turner, J., Chen, D.J., Fishel, R., Giaccia, A.J., Brown, J.M., and Kirchgessner, C.U. (1996). The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and p53 induction. Proc. Natl. Acad. Sci. USA 93, 13825-13830.
13. Gottlieb, T.M., and Jackson, S.P. (1993). The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 72, 131-142.
14. Gottlieb, T.M., and Oren, M. (1996). p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287, 77-102.
15. Gu, W., Shi, X.-L., and Roeder, R.G. (1997). Synergistic activation of transcription by CBP and p53. Nature 387, 819-822.
16. Guidos, C.J., Williams, C.J., Grandal, I., Knowles, G., Huang, M.T.F., and Danska, J.S. (1996). V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev. 10, 2038-2054.
17. Gurley, K.E., and Kemp, G.J. (1996). p53 induction, cell cycle checkpoints, and apoptosis in DNAPK-deficient seid mice. Carcinogenesis 17, 2537-2542.
18. Hartley, K.O., Gell, D., Smith, G.C.M., Zhang, H., Divecha, N., Connelly, M.A., Admon, A., Lees-Miller, S.P., Anderson, C.W., and Jackson, S.P. (1995). DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell 82, 849-856.
19. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
20. Hawley, R.S., and Friend, S.H. (1996). Stange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to p53. Genes Dev. 10, 1383-1388.
21. Huang, L.-C., Clarkin, K.C., and Wahl, G.M. (1996). p53-dependent cell cycle arrests are preserved in DNA-activated protein kinasedeficient mouse fibroblasts. Cancer Res. 56, 2940-2944.
22. Hupp, T.R., and Lane, D.P. (1994). Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases. Cold Spring Harb. Symp. Quant. Biol. 59, 195-206.
23. Hupp, T.R., Meek, D.W., Midgley, C.A., and Lane, D.P. (1992). Regulation of the specific DNA binding function of p53. Cell 71, 875-886.
24. Jones, S.N., Roe, A.E., Donehower, L.A., and Bradley, A. (1995). Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206-208.
25. Juven, T., Barak, Y., Zauberman, A., George, D.L., and Oren, M. (1993). Wild-type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8, 3411-3416.
26. Karin, M., and Hunter, T. (1995). Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5, 747-757.
27. Kastan, M.B., Zhan, Q., El-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B., and Fornace Jr., A.J. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 589-597.
28. Keith, C.T., and Schreiber, S.L. (1995). PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 270, 50-51.
29. Khanna, K.K., Beamish, H., Yan, J., Hobson, K., Williams, R., and Dunn, I. (1995). Nature of G1/S cell cycle checkpoint defect in ataxiatelangiectasia. Oncogene 11, 609-618.
30. Kirchgessner, C.U., Patil, C.K., Evans, J.W., Cuomo, C.A., Fried, L. M., Carter, T., Oettinger, M.A., and Brown, J.M. (1995). DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267, 1178-1183.
31. Kitagawa, M., Higashi, H., Jung, H.-K., Suzuki-Takahashi, I., Ikeda, M., Tamai, K., Kato, J.-Y., Segawa, K., Yoshida, E., Nishimura, S., and Taya, Y. (1996). The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15, 7060-7069.
32. Ko, L.J., and Prives, C. (1996). p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
33. Kubbutat, M.H.G., Jones, S.N., and Vousden, K.H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
34. Kussie, P.M., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A.J., and Pavletich, N.P. (1996). Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948-953.
35. Lees-Miller, S.P., Chen, Y.-R., and Anderson, C.W. (1990). Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen. Mol. Cell. Biol. 10, 6472-6481.
36. Lees-Miller, S.P., Sakaguchi, K, Ullrich, S.J., Appella, E., and Anderson, C.W. (1992). Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol. Cell. Biol. 12, 5041-5049.
37. Lees-Miller, S.P., Godbout, R., Chan, D.W., Weinfeld, M., Day III, R.S., Barron, G.M., and Allalunis-Turner, J. (1995). Absence of p460 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267, 1183-1185.
38. Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
39. Lill, N.L., Grossman, S.R., Ginsberg, D., DeCaprio, J., and Livingston, D.M. (1997). Binding and modulation of p53 by p300/CBP coactivators. Nature 387, 823-827.
40. Lin, J., Chen, J., Elenbaas, B., and Levine, A.J. (1994). Several hydrophobic amino acids in the p53 amino-terminal domain are required for trancriptional activation, binding to mdm2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8, 1235-1246.
41. Lu, X., and Lane, D.P. (1993). Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75, 765-778.
42. Lu, H., and Levine, A.J. (1995). Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc. Natl. Acad. Sci. USA 92, 5154-5158.
43. Maki, C.G., Huibregtse, J.M., and Howley, P.M. (1996). In vivo ubiquitinization and proteasome-mediated degradation of p53. Cancer Res. 56, 2649-2654.
44. Meek, D.W. (1994). Posttranslational modification of p53. Semin. Cancer Biol. 5, 203-210.
45. Milczarek, G.J., Martinez, J., and Bowden, G.T. (1997). p53 phosphorylation: biochemical and functional consequences. Life Sci. 60, 1-11.
46. Momand, J., Zambetti, G.P., Olson, D.C., George, D., and Levine, A.J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245.
47. Morozov, V.E., Falzon, M., Anderson, C.W., and Kuff, E.L. (1994). DNA-dependent protein kinase is activated by nicks and larger single-stranded gaps. J. Biol. Chem. 269, 16684-16688.
48. Nelson, W.G., and Kastan, M.B. (1994). DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14, 1815-1823.
49. Nussenzweig, A., Chen, C., da Costa Soares, V., Sanchez, M., Sokol, K., Nussenzweig, M.C., and Li, G.C. (1996). Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382, 551-555.
50. Oliner, J.D., Pietenpol, J.A., Thiagalingam, S., Gyuris, J., Kinzler, K.W., and Vogelstein, B. (1993). Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 362, 857-860.
51. Pariat, M., Carillo, S., Molinare, M., Salvat, C., Debussche, L., Bracco, L., Milner, J., and Piechaczyk, M. (1997). Proteolysis by calpains: a possible contribution to degradation of p53. Mol. Cell. Biol. 17, 2806-2815.
52. Peterson, S.R., Kurimasa, A., Oshimura, M., Dynan, W.S., Bradbury, E.M., and Chen, D.J. (1995). Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells. Proc. Natl. Acad. Sci. USA 92, 3171-3174.
53. Picksley, S.M., Vojtesek, B., Sparks, A., and Lane, D.P. (1994). Immunochemical analysis of the interaction of p53 with MDM2 - fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene 9, 2523-2529.
54. Rathmell, W.K., Kaufmann, W.K., Hurt, J.C., Byrd, L.L., and Chu, G. (1997). DNA-dependent protein kinase is not required for accumulation of p53 or cell cycle arrest after DNA damage. Cancer Res. 57, 68-74.
55. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D.A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., et al., (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753.
56. Takenaka, I., Morin, F., Seizinger, B.R., and Kley, N. (1995). Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270, 5405-5411.
57. Thut, C.J., Chen, J.-L., Klemm, R., and Tjian, R. (1995). p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science 267, 100-104.
58. Ui, M., Okada, T., Hazeki, K., and Hazeki, O. (1995). Wortmannin as a unique probe for an intracellular signaling protein, phosphoinositide 3-kinase. Trends Biochem. Sci. 20, 303-307.
59. Wang, Y., and Eckhart, W. (1992). Phosphorylation sites in the amino-terminal region of mouse p53. Proc. Natl. Acad. Sci. USA 89, 4231-4235.
60. Wang, Y., and Prives, C. (1995). Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376, 88-91.
61. Wu, X., Bayle, J.H., Olson, D., and Levine, A.J. (1993). The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132.
62. Zhu, C., Bogue, M.A., Lim, D.-S., Hasty, P., and Roth, D.B. (1996). Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86, 379-389.